Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes

Table 2

Comparison of clinical and biochemical characteristics of included patients according to FIB-4 and VCTE values.

	FIB-4	N	Mean	SD	value	VCTE	N	Mean	SD	value
Age	≤1.3	269	59.61	12.10	<0.001	<7.9 kPa	368	62.38	12.24	0.57
	>1.3	164	66.93	10.33		≥7.9 kPa	86	63.20	10.70
VCTE (kPa)	≤1.3	269	6.26	3.46	0.04	<7.9 kPa	368	5.17	1.28	<0.001
	>1.3	164	7.04	4.29		≥7.9 kPa	86	12.35	5.16
CAP (dB/m)	≤1.3	269	301.28	63.36	0.35	<7.9 kPa	368	295.11	66.13	0.024
	>1.3	164	295.07	71.61		≥7.9 kPa	86	312.85	64.54
BMI (kg/m^2)	≤1.3	268	30.87	7.27	0.09	<7.9 kPa	368	30.24	6.89	0.33
	>1.3	164	29.71	6.64		≥7.9 kPa	85	31.07	7.72
HbA1C	≤1.3	269	66.30	22.48	0.004	<7.9 kPa	347	63.39	21.48	0.36
	>1.3	157	60.07	19.78		≥7.9 kPa	82	65.82	22.28
AST	≤1.3	269	21.60	7.92	<0.001	<7.9 kPa	359	23.80	10.98	<0.001
	>1.3	164	36.09	33.55		≥7.9 kPa	86	40.76	44.36
ALT	≤1.3	269	28.79	18.25	<0.001	<7.9 kPa	359	28.96	21.12	<0.001
	>1.3	164	39.16	41.81		≥7.9 kPa	86	47.69	50.00
GGT	≤1.3	266	38.86	34.64	<0.001	<7.9 kPa	355	40.26	43.14	<0.001
	>1.3	164	68.39	117.28		≥7.9 kPa	86	95.26	149.04
ALP	≤1.3	229	76.03	28.74	0.68	<7.9 kPa	307	74.26	27.23	<0.001
	>1.3	147	77.35	29.78		≥7.9 kPa	75	87.07	37.07
PLT	≤1.3	269	279.70	64.64	<0.001	<7.9 kPa	352	253.37	70.15	0.66
	>1.3	164	208.79	55.99		≥7.9 kPa	82	249.62	72.12
TGL	≤1.3	254	2.18	1.62	0.32	<7.9 kPa	346	2.40	5.58	0.74
	>1.3	159	2.70	8.07		≥7.9 kPa	79	2.19	1.86
CHOL	≤1.3	254	4.88	1.35	0.202	<7.9 kPa	346	4.79	1.33	0.57
	>1.3	159	4.71	1.31		≥7.9 kPa	78	4.88	1.38
HDL	≤1.3	236	1.26	0.71	0.85	<7.9 kPa	317	1.29	0.65	0.006
	>1.3	144	1.28	0.39		≥7.9 kPa	74	1.14	0.36
LDL	≤1.3	222	2.85	1.13	0.14	<7.9 kPa	294	2.75	1.10	0.32
	>1.3	133	2.67	1.06		≥7.9 kPa	71	2.89	1.10

VCTE, vibration-controlled transient elastography; CAP, controlled attenuation parameter; BMI, body mass index; CHOL, total cholesterol; TGL, triglycerides.